RiverFront Investment Group »

Tg Therapeutics shares owned by RiverFront Investment Group

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by RiverFront Investment Group from 13F filings

Historical chart of RiverFront Investment Group investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by RiverFront Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by RiverFront Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 24k 54.94

More positions owned by RiverFront Investment Group

Ishares Tr Core Msci Common (IEFA)
Vaneck Etf Trust Semi Common (SMH)
Goldman Sachs Etf Tr Common (GSLC)
Ishares Tr U.s. Tech Common (IYW)
Apple Common (AAPL)
Select Sector Spdr Tr Common (XLK)
Ishares Tr Eafe Value Common (EFV)
Nvidia Corporation Common (NVDA)
J P Morgan Exchange T Common (JIVE)
Spdr Series Trust Por Common (SPAB)
J P Morgan Exchange T Etf - E (JEPI)
Schwab Strategic Tr 5 Common (SCHI)
Vanguard Bd Index Common (BND)
Invesco Qqq Tr Unit S Common (QQQ)
Spdr Series Trust Por Common (SPYM)

View all positions for RiverFront Investment Group

Top funds holding Tg Therapeutics

BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Geode Capital Management
D. E. Shaw & Co
Soleus Capital Management
ClearBridge Advisors
Congress Asset Management
Two Sigma Investments
Jane Street
Goldman Sachs Group
Susquehanna International
Pictet Asset Management Holding SA
Nuveen

View all funds holding Tg Therapeutics